| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B Eite. [Ambulatory diagnosis and outpatient management of patients with hypophyseal adenomas]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete. vol 42. issue 12. 1987-10-21. PMID:3630276. |
in the prolactinomas and the somatotropic adenomas of the pituitary gland a medicamentous secondary therapy with dopamine agonists is possible. |
1987-10-21 |
2023-08-11 |
Not clear |
| C A Otto, J C Marshall, R V Lloyd, P S Sherman, S J Fisher, V L Valoppi, W L Rogers, D M Wielan. Use of DES-treated rats as an animal model for assessment of pituitary adenoma imaging agents. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. vol 13. issue 5. 1987-04-22. PMID:3818319. |
an imaging agent which specifically localized in prolactinomas would be of considerable clinical value for both initial detection and also for monitoring the effects of dopamine agonist therapy. |
1987-04-22 |
2023-08-11 |
human |
| R D Jackson, W B Malarke. Sequential prolactin evaluation of a "cured" patient with recurrence of prolactinoma. The American journal of medicine. vol 82. issue 2. 1987-03-17. PMID:3812533. |
this report describes a male subject with a prolactinoma whose preoperative evaluation demonstrated a resistance of prolactin release to inhibition by dopamine. |
1987-03-17 |
2023-08-11 |
human |
| R D Jackson, W B Malarke. Sequential prolactin evaluation of a "cured" patient with recurrence of prolactinoma. The American journal of medicine. vol 82. issue 2. 1987-03-17. PMID:3812533. |
thus, resistance of prolactin secretion to inhibition by dopamine was present in this patient with a prolactinoma. |
1987-03-17 |
2023-08-11 |
human |
| V De Leo, F Petraglia, S Sardelli, S Danero, A R Genazzani, N D'Anton. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. Obstetrics and gynecology. vol 69. issue 1. 1987-01-29. PMID:3099236. |
in prolactinoma patients, the unresponsiveness of prolactin (prl) to dynamic tests with thyrotropin-releasing hormone (trh) or dopamine agonist or antagonist drugs suggests that the disease is caused by the failure of central dopaminergic inhibition. |
1987-01-29 |
2023-08-11 |
Not clear |
| V De Leo, F Petraglia, S Sardelli, S Danero, A R Genazzani, N D'Anton. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. Obstetrics and gynecology. vol 69. issue 1. 1987-01-29. PMID:3099236. |
the absence of prl secretory response to dopamine or trh in prolactinoma patients also may be an effect of the disease. |
1987-01-29 |
2023-08-11 |
Not clear |
| S W Lamberts, T Verleun, L Hofland, R Oostero. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells. The Journal of clinical endocrinology and metabolism. vol 63. issue 6. 1986-12-29. PMID:3782422. |
the estrogen receptor blocker tamoxifen did not alter prl release, but it did reverse the estradiol-induced insensitivity of the prolactinoma cells to the dopamine agonist bromocriptine. |
1986-12-29 |
2023-08-11 |
human |
| K Seki, K Kato, K Shim. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma. The Journal of clinical endocrinology and metabolism. vol 63. issue 5. 1986-11-19. PMID:3760121. |
to assess the role of endogenous dopaminergic tone in the opioid regulation of lh secretion in such patients, lh responses to an opioid antagonist (naloxone) and a dopamine antagonist (metoclopramide) were determined in 11 women with a prolactinoma. |
1986-11-19 |
2023-08-11 |
Not clear |
| M F Scanlon, J R Peters, J Salvador, S H Richards, R John, S Howell, E D Williams, J P Thomas, R Hal. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery. Clinical endocrinology. vol 24. issue 4. 1986-10-23. PMID:3091297. |
in contrast, the tsh response to acute dopamine antagonism is exaggerated in most patients with small prolactinomas but not in those with stalk-compression hyperprolactinaemia and we have found this to be helpful diagnostically since the presence of an exaggerated tsh response to dopamine antagonism is evidence against the presence of stalk-compression hyperprolactinaemia. |
1986-10-23 |
2023-08-11 |
Not clear |
| S R Ahmed, S M Shale. Discordant responses of prolactinoma to two different dopamine agonists. Clinical endocrinology. vol 24. issue 4. 1986-10-23. PMID:3742834. |
discordant responses of prolactinoma to two different dopamine agonists. |
1986-10-23 |
2023-08-11 |
Not clear |
| A Grossman, R Ross, J A Wass, G M Besse. Depot-bromocriptine treatment for prolactinomas and acromegaly. Clinical endocrinology. vol 24. issue 2. 1986-07-24. PMID:3708874. |
two patients with prolactinomas were resistant to both depot-bromocriptine, and large doses of oral dopamine agonists. |
1986-07-24 |
2023-08-11 |
Not clear |
| C Muhr, M Bergström, P O Lundberg, K Bergström, P Hartvig, H Lundqvist, G Antoni, B Långströ. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone. Journal of computer assisted tomography. vol 10. issue 2. 1986-04-23. PMID:3485123. |
this technique may be useful in improving our understanding of the variable response to medical treatment of prolactinomas with dopamine agonists as well as in the prediction of the effect of such treatment. |
1986-04-23 |
2023-08-11 |
Not clear |
| M Takeda, S Tanino, K Nishinuma, T Matsubayashi, S Yamashita, T Nishimur. A case of hypophyseal prolactinoma with treatable delusions of dermatozoiasis. Acta psychiatrica Scandinavica. vol 72. issue 5. 1986-03-17. PMID:4091030. |
bromocriptine (dopamine agonist) was administered for prolactinoma treatment. |
1986-03-17 |
2023-08-11 |
human |
| S W Lambert. Interactions of steroids with prolactin secretion in vitro. Hormone research. vol 22. issue 3. 1985-12-10. PMID:4054837. |
cultured normal human pituitary cells were shown to be more sensitive to dopamine, if they were preincubated with estradiol, while cultured human prolactinoma cells became insensitive to bromocriptine after they were exposed to estrogens. |
1985-12-10 |
2023-08-11 |
human |
| A Martinez-Campos, J Cornejo, J Garza-Flores, F Velasc. Dysfunction of dopaminergic regulation of prolactin in patients with functioning and nonfunctioning pituitary adenomas and craniopharyngiomas. Fertility and sterility. vol 44. issue 4. 1985-11-25. PMID:4054318. |
the response to domperidone (a dopamine blocking agent) of serum prolactin (prl) levels was compared in 3 patients with amenorrhea-galactorrhea without evidence of a pituitary tumor, 23 patients with prolactinomas (10 cases with histologic confirmation), 7 patients with histologically verified large nonfunctioning pituitary adenomas with normal or moderately elevated basal prl levels, and 6 patients with histologically verified craniopharyngiomas (3 with normal basal prl levels and 3 with elevated prl levels). |
1985-11-25 |
2023-08-11 |
Not clear |
| A Martinez-Campos, J Cornejo, J Garza-Flores, F Velasc. Dysfunction of dopaminergic regulation of prolactin in patients with functioning and nonfunctioning pituitary adenomas and craniopharyngiomas. Fertility and sterility. vol 44. issue 4. 1985-11-25. PMID:4054318. |
whereas dopamine control in cases of prolactinoma is altered at the level of pituitary dopamine receptors, alternative explanations must be found for those tumors with normal basal prl levels and lack of response to domperidone. |
1985-11-25 |
2023-08-11 |
Not clear |
| A Grossman, R Ross, M Charlesworth, C B Adams, J A Wass, I Doniach, G M Besse. The effect of dopamine agonist therapy on large functionless pituitary tumours. Clinical endocrinology. vol 22. issue 5. 1985-10-10. PMID:4028461. |
we conclude that patients with large pituitary tumours and only a mildly elevated serum prolactin are unlikely to have prolactinomas, and that such tumours are not likely to show significant tumour shrinkage with medical treatment with dopamine agonists. |
1985-10-10 |
2023-08-11 |
Not clear |
| J R Peters, M D Rodriguez-Arnao, S M Foord, C Edwards, C Dieguez, S Woodhead, R Hall, M F Scanlo. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia. Journal of endocrinological investigation. vol 8. issue 2. 1985-10-07. PMID:4031383. |
since dopamine (da) has been implicated in the inhibitory control of both tsh and lh, we have compared tsh and lh levels following dopamine (da) receptor blockade with domperidone in patients with hyperprolactinemia due to presumed prolactinomas. |
1985-10-07 |
2023-08-11 |
human |
| R Landgraf, G Rieder, P Schmiedek, D Clados, K Bise, K von Werde. Hormone-active intradural spinal metastasis of a prolactinoma--a case report. Klinische Wochenschrift. vol 63. issue 8. 1985-07-25. PMID:3999624. |
this case of a metastasis of a prolactinoma after operation, radiotherapy, and dopamin agonist treatment stresses the importance of close surveillance of patients with prolactinomas without prl normalization during dopamin agonist therapy and shows for the first time the possibility of ectopic prl production due to an intradural spinal metastasis. |
1985-07-25 |
2023-08-11 |
Not clear |
| D Eljarmak, M Lis, M Cantin, P D Carrière, R Coll. Effects of chronic bromocriptine treatment of an estrone-induced, prolactin-secreting rat pituitary adenoma. Hormone research. vol 21. issue 3. 1985-07-22. PMID:3997065. |
bromocriptine (brom), a dopamine (da) agonist, is commonly and successfully used for long-term treatment of human prolactinomas. |
1985-07-22 |
2023-08-11 |
human |